News
Public · Published
Barclays maintains Harmonic at Equal-Weight, lowers price target to $14 from $16
Barclays kept its Equal-Weight rating on Harmonic and cut its price target to $14 from $16, a 12.5% decrease. The new target implies 37.4% upside from the November 2 close of $10.19.
Published:
Updated:
What happened
Barclays kept its Equal-Weight rating on Harmonic and cut its price target to $14 from $16, a 12.5% decrease. The new target implies 37.4% upside from the November 2 close of $10.19.
Confirmed
Global impact / market context
A lower price target signals the analyst expects less upside in Harmonic's shares than before, even while keeping a neutral Equal-Weight rating that means neither buy nor sell. Long-term holders get a reduced but still positive expected return benchmark to weigh against their own view.
Analyst inference
The target implies 37.4% upside from the $10.19 close, so Barclays still sees meaningful gains ahead despite the cut. The unchanged Equal-Weight rating suggests the revision reflects softer assumptions, not a changed stance on the stock's risk or outlook.
Analyst inference
What to watch
- Barclays lowered its Harmonic price target to $14 from $16, a 12.5% decrease, while keeping an Equal-Weight rating on the stock. Confirmed
- Watch whether other analysts also cut their Harmonic targets, which would suggest broader lower expectations for the company's future profit and revenue. Analyst inference
- Track Harmonic's next results for weaker revenue or higher costs, since that would support the lower target and could shift the neutral rating. Analyst inference
Evidence
- Original source link unavailable